4-溴-3-氯苯肼 | 148993-19-5

• 物质功能分类: 有机原料 - 肼或胲的有机衍生物
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-溴-3-氯苯肼
• 英文名称: 4-Bromo-3-chlorobenzhydrazide
• 英文别名: 4-bromo-3-chlorobenzohydrazide
• CAS: 148993-19-5
• 化学式: C₇H₆BrClN₂O
• 分子量: 249.494
• InChiKey: AVMUCZNGCWTULU-UHFFFAOYSA-N

物化性质

• 熔点：
  171-173°C

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  55.1
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2928000090
• 危险类别：
  IRRITANT

反应信息

• 作为反应物：
  描述：

  4-溴-3-氯苯肼 、 以to yield (4-bromo-3-chlorophenyl)-N-[({[4-(piperidylsulfonyl)phenyl]amino}thioxomethyl)amino]carboxamide (510 mg, 96%) in the first step的产率得到(4-Bromo-3-chlorophenyl)-n-[({[4-(piperidylsulfonyl)phenyl]amino}thioxomethyl)amino]carboxamide
  参考文献：
  名称：

  Organosulfur inhibitors of tyrosine phosphatases

  摘要：

  本发明揭示了酚磷酸酶的有机硫调节剂及其在治疗疾病中的应用。

  公开号：

  US20050065118A1

文献信息

• Polycyclic N-Benzamido Imides with Potent Activity against Vaccinia Virus
  作者：Eva Torres、María D. Duque、Pelayo Camps、Lieve Naesens、Teresa Calvet、Mercè Font-Bardia、Santiago Vázquez

  DOI：10.1002/cmdc.201000306

  日期：2010.12.3

  The synthesis and antiviral activity of a series of novel polycyclic analogues of the orthopoxvirus egress inhibitor tecovirimat (ST-246) is presented. Several of these compounds display sub-micromolar activity against vaccinia virus, and were more potent than cidofovir (CDV). The more active compounds were about 10-fold more active than CDV, with minimum cytotoxic concentrations above 100 μM. Chemical

  介绍了正痘病毒出口抑制剂 tecovirimat (ST-246) 的一系列新型多环类似物的合成和抗病毒活性。其中一些化合物对牛痘病毒表现出亚微摩尔活性，并且比西多福韦 (CDV) 更有效。活性更高的化合物的活性比 CDV 高约 10 倍，最小细胞毒性浓度高于 100 μM。对化合物中存在的两个碳-碳双键进行化学操作，以进一步探索这些新型多环酰亚胺的构效关系。两个碳-碳双键的氢化降低了抗病毒活性，而双键的环丙烷化或环氧化完全消除了抗病毒活性。
• Discovery of Protein–Protein Interaction Inhibitors of Replication Protein A
  作者：James D. Patrone、J. Phillip Kennedy、Andreas O. Frank、Michael D. Feldkamp、Bhavatarini Vangamudi、Nicholas F. Pelz、Olivia W. Rossanese、Alex G. Waterson、Walter J. Chazin、Stephen W. Fesik

  DOI：10.1021/ml400032y

  日期：2013.7.11

  Replication protein A (RPA) is a ssDNA binding protein that is essential for DNA replication and repair. The initiation of the DNA damage response by RPA is mediated by protein protein interactions involving the N-terminal domain of the 70 kDa subunit with partner proteins. Inhibition of these interactions increases sensitivity toward DNA damage and replication stress and may therefore be a potential strategy for cancer drug discovery. Toward this end, we have discovered two lead series of compounds, derived from hits obtained from a fragment-based screen that bind to RPA70N with low micromolar affinity and inhibit the binding of an ATRIP-derived peptide to RPA. These compounds may offer a promising starting point for the discovery of clinically useful RP inhibitors.
• ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES
  申请人：Structural Bioinformatics Inc.

  公开号：EP1446110A2

  公开（公告）日：2004-08-18
• [EN] ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES<br/>[FR] ORGANOSULFURES INHIBITEURS DE TYROSINE PHOSPHATASES
  申请人：STRUCTURAL BIOINFORMATICS INC

  公开号：WO2003032916A2

  公开（公告）日：2003-04-24

  Organosulfur modulators of tyrosine phosphatases and their use in the treatment of disease are disclosed.